Impact of positive Donor-Specific HLA Antibodies (DSA) crossmatch on graft survival in ABO incompatible liver-kidney transplantation: A case report
We present a patient with positive donor-specific antibodies (DSA) and crossmatch of ABO-incompatible (ABOi) combined liver and kidney transplantation (CLKT). Antibody-mediated rejection did not occur and the graft has survived for over 1 year at the time of writing without infectious complications. A 56-year-old man with positive DSA and positive crossmatch underwent living donor CLKT. The preoperative protocol for ABOi consisted of a single dose of rituximab and total plasma exchange (TPE). The result of Anti-B antibody titer for IgG was 1:32.
Source: Transplantation Proceedings - Category: Transplant Surgery Authors: Chia-En Hsieh, Yu Yang, Kuo-Hua Lin, Chun-Chi Chen, Chih-Jan Ko, Ya-Lan Hsu, Chia-Cheng Lin, Yu-Ju Hung, Ping-Yi Lin, Su-Han Wang, Yao-Li Chen Source Type: research
More News: Chia | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Rituxan | Transplants | Urology & Nephrology